NextCure, Inc. — Director's Dealing 2019

May 15, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2019-05-13

Reporting Person: Sofinnova Venture Partners IX, L.P. (10% Owner)
Reporting Person: Sofinnova Management IX, L.L.C. (10% Owner)
Reporting Person: HEALY JAMES (10% Owner)
Reporting Person: Mehra Anand (10% Owner)
Reporting Person: POWELL MICHAEL (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-13	Common Stock	C	278759	—	Acquired	278759	Direct
2019-05-13	Common Stock	C	464599	—	Acquired	743358	Direct
2019-05-13	Common Stock	C	908785	—	Acquired	1652143	Direct
2019-05-13	Common Stock	C	469713	—	Acquired	2121856	Direct
2019-05-13	Common Stock	P	400000	$15	Acquired	2521856	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-13	Series A-1 Preferred Stock	$	C	2239500	Disposed		Common Stock (278759)	Direct
2019-05-13	Series A-2 Preferred Stock	$	C	3732500	Disposed		Common Stock (464599)	Direct
2019-05-13	Series A-3 Preferred Stock	$	C	7301000	Disposed		Common Stock (908785)	Direct
2019-05-13	Series B-1 Preferred Stock	$	C	3773585	Disposed		Common Stock (469713)	Direct

Footnotes

F1: The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.

F2: The shares are held directly by Sofinnova Venture Partners IX, L.P. ("SVP IX"). Sofinnova Management IX, L.L.C. ("SM IX") is the general partner of SVP IX and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP IX. Dr. James I. Healy, Michael F. Powell, Ph.D., and Dr. Anand Mehra are the managing members of SM IX and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP IX. Each of the reporting persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.